NovoCure (NVCR) Cash from Operations (2014 - 2026)
NovoCure (NVCR) posted Cash from Operations of 8132000.0 for Q2 2026, up 160.16% sequentially from 13517000.0 in Q1 2026, and up 151.03% YoY from 3239464.85 in Q2 2025.
NovoCure (NVCR) Cash from Operations (2014 - 2026) Analysis & Trends
NovoCure has reported Cash from Operations for 13 years, with the latest figure at 8132000.0 in Q2 2026.
- Quarterly Cash from Operations rose 151.03% year-over-year to 8132000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 2815000.0 (up 93.7% YoY) and the FY2025 annual result came in at 49031000.0, down 85.94% from the prior year.
- Cash from Operations rose to 8132000.0 in Q2 2026 per NVCR's latest filing, from 13517000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 22420000.0 in Q3 2022 and troughed at 35665000.0 in Q1 2025.
- A 5-year average of 6851833.33 and a median of 8612000.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations surged 153.72% in 2024, then sank 826.51% in 2025.
- Over 5 years, Cash from Operations stood at 3707000.0 in 2022, then sank by 292.72% to 14558000.0 in 2023, then jumped by 76.29% to 3451000.0 in 2024, then plunged by 421.7% to 18004000.0 in 2025, then soared by 145.17% to 8132000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 8132000.0, 13517000.0, and 18004000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 367.10 Mn |
| 10 | NovoCure | 2.04 Bn | 1.60 Bn | 142.48 Mn | 8.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.13 Mn |
| Jun 30, 2026 | 8.13 Mn |
| Mar 31, 2026 | -13.52 Mn |
| Mar 31, 2026 | -13.52 Mn |
| Dec 31, 2025 | -18.00 Mn |
| Dec 31, 2025 | -18.00 Mn |
| Sep 30, 2025 | 20.57 Mn |
| Sep 30, 2025 | 20.57 Mn |
| Jun 30, 2025 | -15.94 Mn |
| Jun 30, 2025 | -15.94 Mn |
| Mar 31, 2025 | -35.67 Mn |
| Mar 31, 2025 | -35.67 Mn |
| Dec 31, 2024 | -3.45 Mn |
| Dec 31, 2024 | -3.45 Mn |
| Sep 30, 2024 | 10.38 Mn |
| Sep 30, 2024 | 10.38 Mn |
| Jun 30, 2024 | -1.72 Mn |
| Jun 30, 2024 | -1.72 Mn |
| Mar 31, 2024 | -31.57 Mn |
| Mar 31, 2024 | -31.57 Mn |